Panbela Therapeutics Inc.

09/24/2024 | Press release | Distributed by Public on 09/24/2024 06:09

First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center